RU2018132749A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2018132749A3 RU2018132749A3 RU2018132749A RU2018132749A RU2018132749A3 RU 2018132749 A3 RU2018132749 A3 RU 2018132749A3 RU 2018132749 A RU2018132749 A RU 2018132749A RU 2018132749 A RU2018132749 A RU 2018132749A RU 2018132749 A3 RU2018132749 A3 RU 2018132749A3
- Authority
- RU
- Russia
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610107901 | 2016-02-26 | ||
| CN201610107901.X | 2016-02-26 | ||
| PCT/CN2017/074756 WO2017144015A1 (zh) | 2016-02-26 | 2017-02-24 | 一种新毒素及其中间体的制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2018132749A RU2018132749A (ru) | 2020-03-26 |
| RU2018132749A3 true RU2018132749A3 (ru) | 2020-04-14 |
Family
ID=59685835
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2018132749A RU2018132749A (ru) | 2016-02-26 | 2017-02-24 | Новый токсин и способ получения его промежуточного соединения |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10513510B2 (ru) |
| EP (1) | EP3421463A4 (ru) |
| JP (1) | JP2019510000A (ru) |
| KR (1) | KR20180115743A (ru) |
| CN (1) | CN107531680B (ru) |
| AU (1) | AU2017223532A1 (ru) |
| BR (1) | BR112018016983A2 (ru) |
| CA (1) | CA3015098A1 (ru) |
| HK (1) | HK1244805A1 (ru) |
| MX (1) | MX2018010128A (ru) |
| RU (1) | RU2018132749A (ru) |
| TW (1) | TWI732826B (ru) |
| WO (1) | WO2017144015A1 (ru) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109963835B (zh) * | 2017-09-04 | 2022-10-21 | 江苏恒瑞医药股份有限公司 | 一种新毒素及其中间体的制备方法 |
| CN112390853A (zh) * | 2019-08-11 | 2021-02-23 | 复旦大学 | 海兔毒素10类似物及其制备方法 |
| AU2021317378A1 (en) | 2020-07-27 | 2023-03-09 | Tuojie Biotech (Shanghai) Co., Ltd. | Anti-CD79B antibody-drug conjugate, and preparation method therefor and pharmaceutical use thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2861170B1 (fr) | 2003-10-16 | 2006-01-20 | Tijani Gharbi | Dispositif optique pour determiner au moins une caracteristique dimensionnelle d'une goutte de liquide |
| PL1725249T3 (pl) * | 2003-11-06 | 2014-06-30 | Seattle Genetics Inc | Związki monometylowaliny zdolne do sprzęgania do ligandów |
| EP3088004B1 (en) * | 2004-09-23 | 2018-03-28 | Genentech, Inc. | Cysteine engineered antibodies and conjugates |
| AR064561A1 (es) | 2006-12-28 | 2009-04-08 | Actelion Pharmaceuticals Ltd | Derivados de 2-aza-biciclo[3.1.0]hexano y su uso en la preparacion de un medicamento para el tratamiento de enfermedades relacionadas con disfunciones generales del sistema de la orexina. |
| TWI476190B (zh) * | 2009-03-30 | 2015-03-11 | 必治妥美雅史谷比公司 | C型肝炎病毒抑制劑 |
| CN106117312A (zh) | 2011-04-21 | 2016-11-16 | 西雅图基因公司 | 新的结合剂‑药物缀合物(adc)及其用途 |
| JP6192233B2 (ja) | 2011-11-17 | 2017-09-06 | ファイザー・インク | 細胞毒性ペプチドおよびその抗体薬物コンジュゲート |
| SG11201403085PA (en) | 2011-12-14 | 2014-10-30 | Seattle Genetics Inc | Fgfr antibody drug conjugates (adcs) and the use thereof |
| FR3005051A1 (fr) * | 2013-04-25 | 2014-10-31 | Pf Medicament | Derives de la dolastatine 10 et d'auristatines |
| US10314921B2 (en) * | 2014-04-25 | 2019-06-11 | Pierre Fabre Medicament | Antibody-drug-conjugate and its use for the treatment of cancer |
| CN106794258B (zh) | 2015-02-15 | 2019-07-12 | 江苏恒瑞医药股份有限公司 | 配体-细胞毒性药物偶联物、其制备方法及其应用 |
| CN106188293A (zh) * | 2015-04-17 | 2016-12-07 | 江苏恒瑞医药股份有限公司 | 抗c-Met抗体和抗c-Met抗体-细胞毒性药物偶联物及其医药用途 |
-
2017
- 2017-02-24 TW TW106106404A patent/TWI732826B/zh not_active IP Right Cessation
- 2017-02-24 HK HK18104330.1A patent/HK1244805A1/zh unknown
- 2017-02-24 BR BR112018016983-8A patent/BR112018016983A2/pt not_active IP Right Cessation
- 2017-02-24 KR KR1020187026912A patent/KR20180115743A/ko not_active Withdrawn
- 2017-02-24 CA CA3015098A patent/CA3015098A1/en not_active Abandoned
- 2017-02-24 US US16/078,396 patent/US10513510B2/en not_active Expired - Fee Related
- 2017-02-24 AU AU2017223532A patent/AU2017223532A1/en not_active Abandoned
- 2017-02-24 JP JP2018544080A patent/JP2019510000A/ja active Pending
- 2017-02-24 CN CN201780001254.7A patent/CN107531680B/zh active Active
- 2017-02-24 RU RU2018132749A patent/RU2018132749A/ru not_active Application Discontinuation
- 2017-02-24 EP EP17755844.2A patent/EP3421463A4/en not_active Withdrawn
- 2017-02-24 MX MX2018010128A patent/MX2018010128A/es unknown
- 2017-02-24 WO PCT/CN2017/074756 patent/WO2017144015A1/zh not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CN107531680A (zh) | 2018-01-02 |
| AU2017223532A1 (en) | 2018-08-30 |
| TW201730185A (zh) | 2017-09-01 |
| TWI732826B (zh) | 2021-07-11 |
| MX2018010128A (es) | 2019-01-21 |
| US10513510B2 (en) | 2019-12-24 |
| JP2019510000A (ja) | 2019-04-11 |
| EP3421463A4 (en) | 2019-10-23 |
| CN107531680B (zh) | 2020-09-11 |
| RU2018132749A (ru) | 2020-03-26 |
| HK1244805A1 (zh) | 2018-08-17 |
| WO2017144015A1 (zh) | 2017-08-31 |
| US20190055223A1 (en) | 2019-02-21 |
| CA3015098A1 (en) | 2017-08-31 |
| BR112018016983A2 (pt) | 2018-12-26 |
| KR20180115743A (ko) | 2018-10-23 |
| EP3421463A1 (en) | 2019-01-02 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20200909 |